DOJ secures $305 million in penalties to resolve generics case
The Department of Justice has agreed to defer its price-fixing prosecution of Teva Pharmaceuticals after the generic drugmaker agreed to pay the largest domestic cartel fine in US history and divest a cholesterol medication.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10